Log in to save to my catalogue

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnose...

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnose...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85d07ceb4ffb4350a7da29ebc2f8331e

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial

About this item

Full title

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2021-12, Vol.11 (12), p.197-197, Article 197

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_85d07ceb4ffb4350a7da29ebc2f8331e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85d07ceb4ffb4350a7da29ebc2f8331e

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-021-00590-5

How to access this item